Chronic Fatigue Syndrome Trial, Recruiting NCT06291870 Sponsor: VA Office of Research and Development Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT06291870
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older
  • You must have been previously diagnosed with COVID-19 at some point
  • People of all genders, races, and ethnicities are welcome to participate
  • People who have been diagnosed with sleep apnea (a condition where breathing stops and starts during sleep, confirmed by a sleep study) and have a history of COVID-19 may also be eligible for a specific part of the study

Who may not be able to join:

  • People who are not able to give their own consent to participate in the study
  • People who are currently experiencing thoughts of suicide
  • Children and anyone under 18 years of age
  • Women who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Susmita Chowdhuri, MD MS, John D. Dingell VA Medical Center, Detroit, MI

Phone: (313) 576-4464

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 January 2023
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Neurocognitive function Trails A and Trails B; Neurocognitive function PASAT; Neurocognitive function Stroop color-word interference; Neurocognitive function DIGIT; Neurocognitive function WASI; Neurocognitive function WMS; Neurocognitive function PVT; Neurocognitive function HVLT-R; Sleepiness ESS; Sleep quality PSQI; Quality of life SF-36v2; Quality of life FOSQ; Quality of life SGRQ; Fatigue Severity; PROMISE Sleep Disturbance; Horne and Osteberg Morningness/Eveningness Questionnaire; Mini Mental State Examination (MMSE); Borg Scale; Dyspnea: Six-minute walk test (6MWT) distance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov